Social Media Ideas for Ai Biotech

<![CDATA[The Only AI Simulation Built for Life Sciences ]]>

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and...

Immunai, a leading AI biotech company specialized in mapping the human immune system, today announced a multi-project collaboration and an initial discovery program with Boehringe...

BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared intelligence platform”...

Absci Corporation: A Big Binary Approaching In Alopecia

How iBio aims to stand out in obesity by targeting ‘both sides of the equation’ for antibody discovery

Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery platform it picked up in 2022.

IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow

Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imaging, Omics, and Broader Health-Data Applications Ahead of Planned AAIC 2026 Demons...

Insilico Medicine, Bora Pharmaceuticals partner on AI drug discovery and development

Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufac...

IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Tim...

Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and c...

Rethinking precision oncology drug development: AI and tumor biology for smarter therapeutic programs

Discover how precision oncology companies are using AI and patient-relevant biology to reduce clinical trial failures in cancer. The post Rethinking precision oncology drug develop...

<![CDATA[Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive ]]>

NIIMBL to Support Vector Production and AI-Ready Training Projects

Improved viral vector production and an AI-ready workforce are the future of the drug industry, according to NIIMBL, which has selected several AAV and AI-focused projects for supp...

With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform

TechBio outfit Immunai is continuing its parade of Big Pharma partnerships with its third such pact this year, this time with German drugmaker Boehringer Ingelheim.

Anthropic Launches Claude Science to Court Pharma Ahead of IPO

Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sec...

StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III

Insilico Medicine, an AI-based drug developer whose profile within biopharma has risen with its recent collaborations with industry giants, has offered investors an upbeat revenue...

AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline

Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharma’s decision to race the molecule into p...

Bristol Myers deepens AI investment with Anthropic deal

The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-da...

How AI is reshaping biopharma decision-making

AI is accelerating discovery, but only when paired with expert insight and trusted data. Hear how leaders are rethinking decision-making in biopharma.

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation

Leveraging Advanced Diagnostics and Screenings to Provide Personalized Proactive Care

Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President  

IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Agilent Technologies Inc. (NYSE: A) announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the...

<![CDATA[Insilico Announces Collaboration with SK Biopharmaceutical for AI-Powered CNS Treatment]]>

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model